{"id":9336,"date":"2025-12-09T14:18:25","date_gmt":"2025-12-09T11:18:25","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=9336"},"modified":"2025-12-09T14:18:25","modified_gmt":"2025-12-09T11:18:25","slug":"diagnosis-treatment-of-renal-artery-stenosis-ras","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/diagnosis-treatment-of-renal-artery-stenosis-ras\/","title":{"rendered":"Diagnosis & Treatment of Renal Artery Stenosis (RAS)"},"content":{"rendered":"
Diagnosis & Treatment of Renal Artery Stenosis (RAS)<\/div>\n
<\/div>\n
Source (Hypertension News \u2013 Dec 2025)<\/div>\n
<\/div>\n
Keynotes:<\/div>\n
1.\u2060 \u2060Types of Renal Artery Stenosis<\/div>\n
\u2022 Atherosclerotic RAS (ARAS): majority of cases; driven by flow disturbances + intrarenal inflammation.<\/span><\/div>\n
\u2022 Fibromuscular Dysplasia (FMD): increasingly recognized; kidney structure preserved, similar to essential hypertension.<\/span><\/div>\n
<\/div>\n
2.\u2060 \u2060When to Suspect RAS<\/div>\n
<\/div>\n
Key clinical clues:<\/div>\n
\u2022 Resistant or sudden-onset hypertension<\/span><\/div>\n
\u2022 Ischemic nephropathy or unexplained decline in eGFR<\/span><\/div>\n
\u2022 \u201cCardiac destabilization syndromes\u201d: flash pulmonary edema, recurrent HF, ACS<\/span><\/div>\n
\u2022 Abdominal bruit, unexplained hypokalemia<\/span><\/div>\n
\u2022 Strongest predictors of significant RAS:<\/span><\/div>\n
\u2022 Kidney length asymmetry \u226510%<\/span><\/div>\n
\u2022 Peripheral \/ extra-renal atherosclerosis<\/span><\/div>\n
\u2022 Newly developed hypertension<\/span><\/div>\n
<\/div>\n
3.\u2060 \u2060Diagnostic Imaging Modalities for RAS<\/div>\n
<\/div>\n
A. Duplex Ultrasound (DUS)<\/div>\n
\u2022 Pros: Noninvasive, no radiation, inexpensive<\/span><\/div>\n
\u2022 Cons: Operator-dependent, limited in obese\/abdominal gas<\/span><\/div>\n
<\/div>\n
B. Computed Tomography Angiography (CTA)<\/div>\n
\u2022 Pros: Excellent anatomical detail<\/span><\/div>\n
\u2022 Cons: Uses iodinated contrast \u2192 may worsen kidney function in CKD; exposes to radiation<\/span><\/div>\n
<\/div>\n
C. Magnetic Resonance Angiography (MRA)<\/div>\n
\u2022 Pros: High-quality arterial images WITHOUT ionizing radiation<\/span><\/div>\n
\u2022 Kidney Safety:<\/span><\/div>\n
\u2022 Safe when using modern Group II gadolinium agents<\/span><\/div>\n
\u2022 Avoid only in eGFR < 30 mL\/min\/1.73m\u00b2 if Group I gadolinium is used (risk of NSF)<\/span><\/div>\n
\u2022 Thus: MRA generally does NOT harm kidneys when proper agents are used<\/span><\/div>\n
<\/div>\n
D. Digital Subtraction Angiography (DSA) \u2014 Gold Standard<\/div>\n
\u2022 Pros: Most accurate; allows immediate intervention<\/span><\/div>\n
\u2022 Cons: Invasive; uses iodinated contrast + radiation<\/span><\/div>\n
<\/div>\n
Important Clarification<\/div>\n
\u2022 All imaging shows anatomy only, not whether stenosis is hemodynamically or clinically significant.<\/span><\/div>\n
\u2022 No biomarker reliably distinguishes true renovascular hypertension.<\/span><\/div>\n
<\/div>\n
4.\u2060 \u2060Treatment Options<\/div>\n
\u2022 Medical therapy: first-line for most cases<\/span><\/div>\n
\u2022 Percutaneous Transluminal Renal Angioplasty (PTRA \u00b1 stenting)<\/span><\/div>\n
\u2022 Surgery: rarely used today<\/span><\/div>\n
<\/div>\n
Evidence Summary from Trials (ASTRAL, CORAL, others):<\/div>\n
\u2022 No major benefit of angioplasty vs. medical therapy in:<\/span><\/div>\n
\u2022 Cardiovascular mortality<\/span><\/div>\n
\u2022 CVD events<\/span><\/div>\n
\u2022 Preserving kidney function<\/span><\/div>\n
\u2022 Blood pressure reduction<\/span><\/div>\n
\u2022 Small reduction in number of antihypertensive drugs (~0.4)<\/span><\/div>\n
<\/div>\n
Limitations of trials: high heterogeneity, low representation of advanced disease.<\/div>\n
<\/div>\n
5.\u2060 \u2060Current Interventional Perspective<\/div>\n
\u2022 Some recommend revascularization only when pressure-gradient testing suggests hemodynamic significance \u2014 but no evidence this improves outcomes.<\/span><\/div>\n
\u2022 ACC\/AHA\/SCAI \u201cAppropriate Use\u201d Criteria support angioplasty in:<\/span><\/div>\n
\u2022 Cardiac destabilization syndromes<\/span><\/div>\n
\u2022 Rapidly worsening kidney function<\/span><\/div>\n
\u2022 Stage IV CKD + resistant HTN with bilateral RAS<\/span><\/div>\n
\u2022 RAS in a solitary functioning kidney<\/span><\/div>\n
\u2022 Not recommended for incidental or newly discovered asymptomatic ARAS.<\/span><\/div>\n
<\/div>\n
6.\u2060 \u2060Management of Fibromuscular Dysplasia (FMD)<\/div>\n
\u2022 Anti-atherosclerotic therapy not required (non-atherosclerotic disease).<\/span><\/div>\n
\u2022 Angioplasty reasonable in patients <50 years with significant stenosis.<\/span><\/div>\n
\u2022 No randomized trials exist.<\/span><\/div>\n
<\/div>\n
7.\u2060 \u2060Unilateral vs Bilateral RAS(JACC Cardiovasc Interv 2019\u2060 ACC\/SCAI)<\/div>\n
\u2022 Most likely to benefit from revascularization due to:<\/span><\/div>\n
\u2022 Severe RAAS activation<\/span><\/div>\n
\u2022 Sodium\/water retention \u2192 volume overload<\/span><\/div>\n
\u2022 Declining GFR<\/span><\/div>\n
\u2022 Recurrent flash pulmonary edema \/ HF<\/span><\/div>\n
\u2022 Hemodynamic instability<\/span><\/div>\n
<\/div>\n
Selected unilateral high-grade RAS cases may also benefit, especially when:<\/div>\n
\u2022 The affected kidney shows rapid decline<\/span><\/div>\n
\u2022 Blood pressure becomes destabilized<\/span><\/div>\n
\u2022 The patient has a solitary functioning kidney<\/span><\/div>\n
<\/div>\n
Source: ACC\/SCAI Appropriate Use Criteria (JACC Cardiovasc Interv 2019)<\/div>\n
<\/div>\n
ARR Clarification<\/div>\n
<\/div>\n
The aldosterone\u2013renin ratio (ARR) is not useful in diagnosing renovascular hypertension because:<\/div>\n
\u2022 Both renin and aldosterone rise proportionally in RAS<\/span><\/div>\n
\u2022 Unlike primary aldosteronism, where aldosterone rises disproportionately<\/span><\/div>\n
<\/div>\n
8.\u2060 \u2060Overall Clinical Conclusion<\/div>\n
\u2022 No single evidence-based algorithm exists for RAS management.<\/span><\/div>\n
\u2022 Best practice today:<\/span><\/div>\n
\u2022 Screen with CTA<\/span><\/div>\n
\u2022 Confirm with DSA<\/span><\/div>\n
\u2022 Decide on angioplasty individually, based on symptoms and kidney function<\/span><\/div>\n
\u2022 Apply aggressive cardiovascular prevention (statins, antiplatelets) in ARAS<\/span><\/div>\n
https:\/\/ish-world.com\/document\/1764854170.pdf<\/a><\/div>\n
<\/div>\n","protected":false},"excerpt":{"rendered":"

Diagnosis & Treatment of Renal Artery Stenosis (RAS) Source (Hypertension News \u2013 Dec 2025) Keynotes: 1.\u2060 \u2060Types of Renal Artery Stenosis \u2022 Atherosclerotic RAS (ARAS): majority of cases; driven by flow disturbances + intrarenal inflammation. \u2022 Fibromuscular Dysplasia (FMD): increasingly recognized; kidney structure preserved, similar to essential hypertension. 2.\u2060 \u2060When to Suspect RAS Key clinical […]<\/p>\n","protected":false},"author":145,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-9336","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/9336","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/145"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=9336"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/9336\/revisions"}],"predecessor-version":[{"id":9337,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/9336\/revisions\/9337"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=9336"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=9336"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=9336"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}